COVID FAQ – Preventative medication and antiviral treatments

MS Plus has put together a brief Q&A to help you navigate the latest information and advice on COVID preventative medication and antivirals.

MS Plus Executive Manager Client Engagement and Wellbeing Jodi Haartsen is once again joined by Neurologist and Associate Professor Anneke Van Der Walt and Clinical Nurse Consultant Louise Rath from The Alfred.

Please note: this video discusses a preventative medication and antiviral treatments for COVID. However, you may not require treatment – please seek advice from your healthcare team.




New campaign shines light on life-changing MS Nurse Care

MS Australia has today launched a new campaign at Parliament House on World MS Day (30 May) to raise awareness of the crucial role played by MS Nurses.

Revolutionising MS Treatment: New form of Tysabri® recommended for PBS listing

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of natalizumab (Tysabri®) pre-filled syringe for subcutaneous (under the skin) injection on the Pharmaceutical Benefit Scheme (PBS).

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More
XX chromosomesSimon's story

Newsletter subscription

  • Enter your details

COVID FAQ – Preventative medication and antiviral treatments